Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Vaccines

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    November 2025
  1. QASEEM A, Wilt TJ, Harrod CS, Obley AJ, et al
    Influenza Vaccines for 2025-2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
    Ann Intern Med. 2025 Nov 18. doi: 10.7326/ANNALS-25-04056.
    PubMed     Abstract available



  2. Web Exclusive. Annals Video Summary - Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
    Ann Intern Med. 2025 Nov 18:e2504658VS. doi: 10.7326/ANNALS-25-04658.
    PubMed    


  3. DOBRESCU AI, Sharifan A, Sommer I, Neubauer-Bruckner CIA, et al
    Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
    Ann Intern Med. 2025 Nov 18. doi: 10.7326/ANNALS-25-04028.
    PubMed     Abstract available


  4. SHABBIR R, Shabbir Z
    A Reminder in Every Story: The Cost of Vaccine Hesitancy.
    Ann Intern Med. 2025 Nov 11. doi: 10.7326/ANNALS-25-02508.
    PubMed    


  5. BOEDER N, Butler K
    Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
    Ann Intern Med. 2025;178:1673.
    PubMed    


  6. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
    Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
    Ann Intern Med. 2025;178:1674-1675.
    PubMed    


    October 2025
  7. VIELOT NA, Jonsson Funk M, Sturmer T, Fix J, et al
    Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine.
    Ann Intern Med. 2025 Oct 14. doi: 10.7326/ANNALS-24-02409.
    PubMed     Abstract available


    September 2025
  8. ANDREWS RA, Erickson SM, Goldman JM, Moyer DV, et al
    Deja Flu All Over Again: The Risk for Overwhelm of the U.S. Health Care System by Vaccine-Preventable and Modifiable Diseases.
    Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-25-03999.
    PubMed    


  9. LAINE C, Turner BJ, Qaseem A, Moyer DV, et al
    Vaccines: Decision Making Amid Conflicting Recommendations.
    Ann Intern Med. 2025 Sep 16. doi: 10.7326/ANNALS-25-04054.
    PubMed    


    July 2025
  10. KOBAYASHI M, Loehr J, Caine VA, Cohen AL, et al
    New Pneumococcal Vaccine Recommendation for U.S. Adults Aged 50 Years and Older-Promise and Challenges.
    Ann Intern Med. 2025 Jul 22. doi: 10.7326/ANNALS-25-01178.
    PubMed    



  11. Correction: Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood.
    Ann Intern Med. 2025 Jul 17. doi: 10.7326/ANNALS-25-03233.
    PubMed    



  12. Summary for Patients: Aluminum in Vaccines and the Risk for Childhood Disease.
    Ann Intern Med. 2025 Jul 15. doi: 10.7326/ANNALS-25-00997.
    PubMed    


  13. ANDERSSON NW, Bech Svalgaard I, Hoffmann SS, Hviid A, et al
    Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood : A Nationwide Cohort Study.
    Ann Intern Med. 2025 Jul 15. doi: 10.7326/ANNALS-25-00997.
    PubMed     Abstract available


    June 2025
  14. GOLDMAN JM, Fryhofer SA
    Preserving Scientific Integrity in Vaccine Policy: The Role of, and Risk to, the CDC's Advisory Committee on Immunization Practices.
    Ann Intern Med. 2025 Jun 24. doi: 10.7326/ANNALS-25-02806.
    PubMed    


    May 2025
  15. JACOBS JW, Booth GS, Lewis-Newby M, Saifee NH, et al
    Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025.
    Ann Intern Med. 2025 May 13. doi: 10.7326/ANNALS-25-00815.
    PubMed     Abstract available


    April 2025
  16. BLUMENTHAL KG, Phillips EJ
    Chronic Urticaria Following HIV mRNA Vaccines: A Challenging Signal in Need of Mechanistic Insight.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-25-01102.
    PubMed    


  17. RIDDLER SA, Moodie Z, Clark J, Yen C, et al
    High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701.
    PubMed     Abstract available


  18. BILINSKI A, Emanuel N, Ciaranello A
    Sins of Omission: Model-Based Estimates of the Health Effects of Excluding Pregnant Participants From Randomized Controlled Trials.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-00689.
    PubMed     Abstract available


  19. DACSO CC
    Coadministration of RSV + influenza or COVID-19 vaccines was noninferior to separate administration for immune responses in adults aged >/=50 y.
    Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00904.
    PubMed     Abstract available


    February 2025
  20. IOANNOU GN, Berry K, Rajeevan N, Li Y, et al
    Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-01015.
    PubMed     Abstract available


    December 2024
  21. VASSILOPOULOS S, Mylonakis E
    After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up to 2 y.
    Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02887.
    PubMed     Abstract available


    November 2024
  22. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
    Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
    Ann Intern Med. 2024 Nov 26. doi: 10.7326/M24-0421.
    PubMed     Abstract available


    July 2024
  23. KAUFFMAN RP
    mRNA COVID-19 vaccination during pregnancy was not linked to increased adverse neonatal outcomes.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00621.
    PubMed     Abstract available


  24. FUJIEDA T, Tanimoto T
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:990-991.
    PubMed    


  25. SCHATTNER A
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:990.
    PubMed    


  26. TENFORDE MW, Dawood FS
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:991.
    PubMed    


    June 2024
  27. DUTCHER EG, Epel ES, Mason AE, Hecht FM, et al
    COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M23-2956.
    PubMed     Abstract available


    May 2024

  28. Notice of Retraction: Measles, Mumps, Rubella Vaccination and Autism.
    Ann Intern Med. 2024 May 21. doi: 10.7326/ANNALS-24-00530.
    PubMed    


    April 2024
  29. COSCHI CH, Dodbiba L, Guerry D
    Oncology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520.
    PubMed     Abstract available


    March 2024
  30. WELLS CR, Pandey A, Moghadas SM, Fitzpatrick MC, et al
    Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-2451.
    PubMed     Abstract available


  31. HUITS R, Grubaugh ND, Libman M, Hamer DH, et al
    Resurgence of Dengue in the Era of Genomic Surveillance and Vaccines.
    Ann Intern Med. 2024 Mar 19. doi: 10.7326/M24-0496.
    PubMed    


  32. JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
    Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation Trial.
    Ann Intern Med. 2024 Mar 19. doi: 10.7326/M23-2638.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.